684 related articles for article (PubMed ID: 26425043)
1. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
[TBL] [Abstract][Full Text] [Related]
2. Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD.
Budweiser S; Harlacher M; Pfeifer M; Jörres RA
COPD; 2014 Aug; 11(4):388-400. PubMed ID: 24111878
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease.
Lee JS; Kim SO; Seo JB; Lee JH; Kim EK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Lee SW; Huh JW; Oh YM; Lee SD
Lung; 2013 Aug; 191(4):405-12. PubMed ID: 23715996
[TBL] [Abstract][Full Text] [Related]
4. The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease.
French A; Balfe D; Mirocha JM; Falk JA; Mosenifar Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():1305-12. PubMed ID: 26203237
[TBL] [Abstract][Full Text] [Related]
5. [Relation between pulmonary ventilation parameters, exercise tolerance and quality of life in patients with chronic obstructive lung disease].
Chlumský J; Stĕrbová L; Smolíková L; Matous M; Salajka F
Vnitr Lek; 2002 Apr; 48(4):320-4. PubMed ID: 12061182
[TBL] [Abstract][Full Text] [Related]
6. An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD.
Ozgür ES; Nayci SA; Özge C; Taşdelen B
Respir Care; 2012 Sep; 57(9):1452-9. PubMed ID: 22348294
[TBL] [Abstract][Full Text] [Related]
7. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between expiratory muscle dysfunction and dynamic hyperinflation in advanced chronic obstructive pulmonary disease].
Mota S; Güell R; Barreiro E; Casan P; Gea J; Sanchis J
Arch Bronconeumol; 2009 Oct; 45(10):487-95. PubMed ID: 19631439
[TBL] [Abstract][Full Text] [Related]
10. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD).
Fujimoto H; Asai K; Watanabe T; Kanazawa H; Hirata K
Osaka City Med J; 2011 Jun; 57(1):21-9. PubMed ID: 22106764
[TBL] [Abstract][Full Text] [Related]
11. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
12. Not all measures of hyperinflation are created equal: lung structure and clinical correlates of gas trapping and hyperexpansion in COPD: the Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.
Smith BM; Hoffman EA; Basner RC; Kawut SM; Kalhan R; Barr RG
Chest; 2014 Jun; 145(6):1305-1315. PubMed ID: 24481056
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality in patients with emphysema and severe airflow obstruction.
Martinez FJ; Foster G; Curtis JL; Criner G; Weinmann G; Fishman A; DeCamp MM; Benditt J; Sciurba F; Make B; Mohsenifar Z; Diaz P; Hoffman E; Wise R;
Am J Respir Crit Care Med; 2006 Jun; 173(12):1326-34. PubMed ID: 16543549
[TBL] [Abstract][Full Text] [Related]
14. Effect of obesity on respiratory mechanics during rest and exercise in COPD.
Ora J; Laveneziana P; Wadell K; Preston M; Webb KA; O'Donnell DE
J Appl Physiol (1985); 2011 Jul; 111(1):10-9. PubMed ID: 21350021
[TBL] [Abstract][Full Text] [Related]
15. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function.
Martinez FJ; de Oca MM; Whyte RI; Stetz J; Gay SE; Celli BR
Am J Respir Crit Care Med; 1997 Jun; 155(6):1984-90. PubMed ID: 9196106
[TBL] [Abstract][Full Text] [Related]
16. Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD.
Vassaux C; Torre-Bouscoulet L; Zeineldine S; Cortopassi F; Paz-Díaz H; Celli BR; Pinto-Plata VM
Eur Respir J; 2008 Nov; 32(5):1275-82. PubMed ID: 18550609
[TBL] [Abstract][Full Text] [Related]
17. Different therapeutic responses in chronic obstructive pulmonary disease subgroups.
Lee JS; Huh JW; Chae EJ; Seo JB; Ra SW; Lee JH; Kim EK; Lee YK; Kim TH; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Oh YM; Lee SD
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1104-10. PubMed ID: 21740676
[TBL] [Abstract][Full Text] [Related]
18. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Ogawa T; Watanabe F; Arizono S
Respir Med; 2007 Apr; 101(4):833-8. PubMed ID: 16962758
[TBL] [Abstract][Full Text] [Related]
19. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction.
Foglio K; Carone M; Pagani M; Bianchi L; Jones PW; Ambrosino N
Respir Med; 2000 Mar; 94(3):256-63. PubMed ID: 10783937
[TBL] [Abstract][Full Text] [Related]
20. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Tsukino M; Ikeda A; Koyama H; Izumi T
Am J Respir Crit Care Med; 1998 Oct; 158(4):1185-9. PubMed ID: 9769280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
